WAVE Life Sciences (WVE) Tops Q3 EPS by 6c

WAVE Life Sciences (NASDAQ: WVE) reported Q3 EPS of ($0.42), $0.06 better than the analyst estimate of ($0.48). Revenue for the quarter came in at $290 thousand versus the consensus estimate of $8.73 million.

For earnings history and earnings-related data on WAVE Life Sciences (WVE) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Worried the AI trade has gone too far? Evercore likes these 4 stocks
• Credo Technology pops 3.5% as Evercore initiates with monster $325 price target